AIM microBiome is a biotechnology company specializing in the development of innovative solutions that leverage the human microbiome to improve health outcomes, with a focus on diagnostics, therapeutics, and personalized medicine. The company generates revenue primarily through the commercialization of proprietary microbiome-based tests, research collaborations, and licensing agreements with healthcare and pharmaceutical partners. Founded by experts in microbiology and bioinformatics, AIM microBiome has built a reputation for translating cutting-edge research into clinically actionable products. Notably, the company has contributed to advancements in gut health and immune system modulation, positioning itself as a leader in the rapidly evolving microbiome sector. Candidates should be aware of AIM microBiome’s commitment to scientific rigor, regulatory compliance, and its collaborative approach to innovation in the life sciences industry.